Avalo Therapeutics, Inc. (AVTX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 88.83M | 105.29M | 113.85M | 115.19M | 126.94M | 138.89M | 86.15M | 95.89M | 111.21M | 8.39M | 12.66M | 7.52M |
| Cash & Short-Term Investments | 81.99M | 98.34M | 111.62M | 113.26M | 125.05M | 134.55M | 81.86M | 93.43M | 110.18M | 7.42M | 10.18M | 6.31M |
| Cash Only | 24.99M | 15.86M | 26.96M | 42.29M | 125.05M | 134.55M | 81.86M | 93.43M | 110.18M | 7.42M | 10.18M | 6.31M |
| Short-Term Investments | 57.01M | 82.48M | 84.65M | 70.97M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 611K | 998K | 33K | 35K | 136K | 1.54M | 44K |
| Days Sales Outstanding | - | - | - | - | - | 385.49 | 190.47 | - | - | 134.86 | 308.36 | 63.76 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18K |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | 2.38 |
| Other Current Assets | 6.83M | 6.95M | 2.23M | 1.92M | 1.9M | 3.73M | 3.29M | 2.44M | 1M | 844K | 941K | 1.15M |
| Total Non-Current Assets | 11.06M | 11.17M | 11.25M | 11.4M | 11.58M | 11.84M | 12.31M | 12.41M | 12.52M | 12.6M | 16.61M | 16.72M |
| Property, Plant & Equipment | 375K | 460K | 542K | 686K | 949K | 1.21M | 1.67M | 1.78M | 1.88M | 1.97M | 2.07M | 2.18M |
| Fixed Asset Turnover | - | 0.12x | - | - | - | 0.13x | 0.14x | - | - | 0.28x | 0.11x | 0.28x |
| Goodwill | 10.5M | 10.5M | 10.5M | 10.5M | 10.5M | 10.5M | 10.5M | 10.5M | 10.5M | 10.5M | 14.41M | 14.41M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 183K | 210K | 210K | 210K | 131K | 131K | 131K | 131K | 131K | 131K | 131K | 131K |
| Total Assets | 99.89M | 116.46M | 125.1M | 126.58M | 138.52M | 150.73M | 98.45M | 108.31M | 123.73M | 20.99M | 29.27M | 24.23M |
| Asset Turnover | - | 0.00x | - | - | - | 0.00x | 0.00x | - | - | 0.02x | 0.01x | 0.02x |
| Asset Growth % | -27.89% | -22.74% | 27.06% | 16.87% | 11.96% | 618.01% | 236.37% | 346.9% | 241.46% | -37.08% | -19.91% | -24.79% |
| Total Current Liabilities | 11.6M | 12.94M | 7.97M | 9.26M | 5.62M | 6.96M | 60.67M | 96.4M | 215.7M | 4.62M | 6M | 22.45M |
| Accounts Payable | 356K | 137K | 474K | 2.37M | 681K | 283K | 1.81M | 654K | 916K | 446K | 789K | 751K |
| Days Payables Outstanding | 1.3K | - | - | - | - | 1.11K | -158.81 | 208.27 | -774.64 | -257.06 | 295.17 | 405.9 |
| Short-Term Debt | 328K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.12M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 10.91M | 12.41M | 3.38M | 2.51M | 2.13M | 3.24M | 54.02M | 90.27M | 208.15M | 580K | 449K | 527K |
| Current Ratio | 7.66x | 8.14x | 14.28x | 12.44x | 22.61x | 19.96x | 1.42x | 0.99x | 0.52x | 1.82x | 2.11x | 0.33x |
| Quick Ratio | 7.66x | 8.14x | 14.28x | 12.44x | 22.61x | 19.96x | 1.42x | 0.99x | 0.52x | 1.82x | 2.11x | 0.33x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | -339.77 |
| Total Non-Current Liabilities | 19.97M | 20.47M | 25.58M | 12.75M | 10.29M | 10.74M | 16.7M | 25.52M | 9.11M | 9.07M | 8.57M | 8.75M |
| Long-Term Debt | 2M | 2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 35K | 117K | 197K | 275K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 446K | 434K | 304K | 293K | 278K | 270K | 154K | 168K | 162K | 155K | 164K | 156K |
| Other Non-Current Liabilities | 17.52M | 18M | 25.16M | 12.26M | 9.74M | 10.47M | 16.55M | 25.35M | 8.95M | 8.92M | 8.41M | 8.59M |
| Total Liabilities | 31.57M | 33.41M | 33.55M | 22.01M | 15.91M | 17.7M | 77.38M | 121.92M | 224.81M | 13.69M | 14.57M | 31.2M |
| Total Debt | 2.33M | 2.43M | 555K | 679K | 801K | 568K | 550K | 548K | 545K | 537K | 536K | 14.65M |
| Net Debt | -22.66M | -13.43M | -26.41M | -41.61M | -124.25M | -133.98M | -81.31M | -92.88M | -109.63M | -6.88M | -9.64M | 8.34M |
| Debt / Equity | 0.03x | 0.03x | 0.01x | 0.01x | 0.01x | 0.00x | 0.03x | - | - | 0.07x | 0.04x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | -2.41x | -7.18x |
| Total Equity | 68.32M | 83.05M | 91.55M | 104.57M | 122.61M | 133.03M | 21.08M | -13.61M | -101.08M | 7.3M | 14.7M | -6.97M |
| Equity Growth % | -44.28% | -37.57% | 334.37% | 868.47% | 221.3% | 1721.36% | 43.42% | -95.26% | -1512.97% | 166.92% | 824.61% | -17.11% |
| Book Value per Share | 3.40 | 4.49 | 6.54 | 9.66 | 11.66 | 12.70 | 1.95 | -1.78 | -117.63 | 9.11 | 75.42 | -119.71 |
| Total Shareholders' Equity | 68.32M | 83.05M | 91.55M | 104.57M | 122.61M | 133.03M | 21.08M | -13.61M | -101.08M | 7.3M | 14.7M | -6.97M |
| Common Stock | 25K | 18K | 18K | 11K | 11K | 10K | 10K | 1K | 1K | 1K | 192K | 14K |
| Retained Earnings | -468.15M | -448.52M | -434.8M | -404.18M | -383.41M | -370.26M | -334.92M | -357.96M | -456.42M | -335.13M | -326.97M | -321.74M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -6K | 68K | 41K | -34K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |